In one paragraphArticle in International forum of allergy & rhinology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Conner J MasseyDepartment of Otolaryngology-Head & Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0002-6558-4559 Gretchen M OakleyDepartment of Otolaryngology-Head & Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Richard R OrlandiDepartment of Otolaryngology-Head & Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0001-5374-9144 Shaelene AshbyDepartment of Otolaryngology-Head & Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Jeremiah A AltDepartment of Otolaryngology-Head & Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0003-0560-5028 Kristine A SmithDepartment of Otolaryngology-Head & Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Abigail PulsipherDepartment of Otolaryngology-Head & Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.ORCID 0000-0001-7987-3442 Funding
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9MA Novel Glycosaminoglycan-Based Therapeutic for Chronic RhinosinusitisR44AI126987 · NIAID · GLYCOMIRA, LLC · PI SAVAGE, JUSTIN RODNEY · 2018 to 2022
$4.4MCTSA K12 Program at University of Utah: Early Career Faculty Development ProgramK12TR004413 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI MAUREEN A MURTAUGH, Corrine Ione Voils · 2023 to 2026
$3.9MDevelopment of a Diagnostic Test for Eosinophilic Chronic RhinosinusitisR41AI179525 · NIAID · GLYCOMIRA, LLC · PI PULSIPHER, ABIGAIL · 2023 to 2024
$595kFlight Attendant Medical Research Institute CIA160008National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers 1K12TR004413National Center for Advancing Translational Sciences of the National Institutes of Health under Award Numbers UM1TR004409National Institute of Allergy and Infectious Diseases 1R41AI179525National Institute of Allergy and Infectious Diseases 2R44AI126987NCATS NIH HHS K12 TR004413NCATS NIH HHS UM1 TR004409NIAID NIH HHS R41 AI179525NIAID NIH HHS R44 AI126987
6 · The paper itselfAbstract
key pointsEPX activity has been correlated with eCRS diagnosis and baseline disease severity. Herein, EPX activity is shown to correlate with post-operative antibiotic and steroid use in CRS. EPX activity has potential to act as a prognostic biomarker of CRS disease severity and control.
Indexed as
Eosinophil PeroxidaseRhinitisSinusitisAdultAgedAnti-Bacterial AgentsBiomarkersChronic DiseaseDisease ProgressionFemaleHumansMaleMiddle AgedPostoperative ComplicationsPrognosisRhinosinusitisAnti-Bacterial AgentsBiomarkersEosinophil Peroxidasechronic rhinosinusitisendoscopic sinus surgeryeosinophil peroxidase
Identifiers
PMID38767584
PMCPMC11365801
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390